4//SEC Filing
Tenenbaum Fabian 4
Accession 0001600132-18-000179
CIK 0001600132other
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 4:24 PM ET
Size
5.3 KB
Accession
0001600132-18-000179
Insider Transaction Report
Form 4
Tenenbaum Fabian
Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2018-11-20+1,487,500→ 3,676,197 totalExercise: $0.91Exp: 2028-11-20→ Common Stock (1,487,500 underlying)
Footnotes (1)
- [F1]This option was granted on November 20, 2018. This option vests in quarterly installments over a four-years period from the date of grant.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeother
Related Parties
1- filerCIK 0001641300
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 4:24 PM ET
- Size
- 5.3 KB